Publication | Closed Access

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension

HypertensionAntifibrotic TherapyPulmonary Arterial HypertensionCardiovascular DiseasePharmacologyCardiovascular PharmacologyMyocardial FibrosisVascular BiologySystemic Arterial HypertensionAntifibrotic EffectsMedicineCardiology